Cases 21 - 30 of 69
Novo Nordisk A/S et al v. Champion Health and Wellness Clinics LLC
as 4:2023cv02246
Plaintiff:
Novo Nordisk A/S and Novo Nordisk Inc.
Defendant:
Champion Health and Wellness Clinics LLC
Cause Of Action: 28 U.S.C. § 1331 Fed. Question: Trademark
Novo Nordisk A/S et al v. Pro Health Investments, LLC
as 2:2023cv02369
Plaintiff:
Novo Nordisk A/S and Novo Nordisk Inc.
Defendant:
Pro Health Investments, LLC
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
Novo Nordisk A/S et al v. Ekzotika Corp
as 1:2023cv22256
Plaintiff:
Novo Nordisk A/S and Novo Nordisk Inc.
Defendant:
Ekzotika Corp doing business as Cosmetic Laser Professionals Med Spa
Cause Of Action: 15 U.S.C. § 1114 Trademark Infringement
Novo Nordisk A/S et al v. Flawless Image Medical Aesthetics, LLC
as 5:2023cv00739
Plaintiff:
Novo Nordisk A/S and Novo Nordisk, Inc.
Defendant:
Flawless Image Medical Aesthetics, LLC
Cause Of Action: 15 U.S.C. § 1114 Trademark Infringement (Lanham Act)
Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
as 1:2023cv00179
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Orbicular Pharmaceutical Technologies Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Viatris Inc. et al
as 1:2023cv00101
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Viatris Inc. et al
as 1:2023cv00013
Plaintiff:
Novo Nordisk, Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv01040
Counter Defendant:
Novo Nordisk Inc.
Plaintiff:
Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Biocon Pharma Ltd. et al
as 1:2022cv00937
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Biocon Pharma Ltd., Biocon Ltd. and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
